LXEO compared with AURA: revenue, margins and what each company keeps, and the suppliers and customers both name

LXEOLexeo Therapeutics, Inc.

Mkt capRevenueRevenue

AURAAura Biosciences, Inc.

Mkt capRevenueRevenue

Compare

LXEOLexeo Therapeutics, Inc.

AURAAura Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

rebased to 0%

LXEO, solidAURA, dashed

LXEO: latest quarter not drawable. AURA: latest quarter not drawable.Method ›

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: LXEO, AURA.

Role chip = supplier or customerSource: SEC EDGAR

LXEOLexeo Therapeutics, Inc.

3.14▲+2.61%· post 3.14

Mkt cap$257.6M

AURAAura Biosciences, Inc.

6.14▼−2.46%· post 6.14

ClosedOct 30 '26

Mkt cap$636.7M

Compare

ClosedOct 30 '26

LXEOLexeo Therapeutics, Inc.

AURAAura Biosciences, Inc.

3.14▲+2.61%post 3.14

Price

6.14▼−2.46%post 6.14

$257.6M

Mkt cap

$636.7M

LXEO3.14▲+2.61%vsAURA6.14▼−2.46%ClosedOct 30 '26